nsTeam1RO, nsTeam1RW, nsTeam1_talkRO, nsTeam1_talkRW
6,781
edits
Changes
Jump to navigation
Jump to search
mLine 1:
Line 1: − +
Reverted edits by Albertus (Talk); changed back to last version by Aschlafly
M200 is a monoclonal antibody that is being studied in the treatment of some types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. M200 binds to a protein that is found on cells that line some tumor blood vessels. The primary axon of the antibody is believed to be the binding receptor. It belongs to the family of drugs called angiogenesis inhibitors.
M200 is a monoclonal antibody that is being studied in the treatment of some types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. M200 binds to a protein that is found on cells that line some tumor blood vessels. It belongs to the family of drugs called angiogenesis inhibitors.
M200 is also called volociximab.
M200 is also called volociximab.
[[category:medicine]]
[[category:medicine]]